Good day, and thank you for standing by. Welcome to the TCG BDC, Inc. Q3 2021 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star one on your telephone. Please be advised that today's conference is being recorded. If you require any further assistance, please press star zero. I would now like to hand the conference over to your speaker today, Allison Rudary. Please go ahead. Good morning, and welcome to TCG BDC's Q3 2021 Earnings Call. Last night, we issued an earnings press release and detailed earnings presentation with our quarterly results, a copy of which is available on TCG BDC's Investor Relations website. Following our remarks today, we will hold a question-and-answer session for analysts and institutional investors. This call is being webcast, and a replay will be available on our website. Any forward-looking statements made today do not guarantee future performance, and undue reliance should not be placed on them. These statements are based on current management expectations, and they involve inherent risks and uncertainties, including those identified in the Risk Factors section of our annual report on Form 10-K, that could cause actual results to differ materially from those indicated. TCG BDC assumes no obligation to update forward-looking statements at any time. With that, I'll turn the call over to our Chief Executive Officer, Linda Pace. Thank you, Allison. Good morning, everyone, and thank you all for joining us on our call this morning to discuss our Q3 2021 results. Joining me on today's call is our Chief Investment Officer, Taylor Boswell, and our Chief Financial Officer, Tom Hennigan. I'd like to focus my remarks today on three areas. First, I'll provide an overview of this quarter's strong financial results. Second, I'll touch on the portfolio and credit highlights. Finally, I want to conclude with some thoughts on our current positioning. Let me begin with an overview of this quarter's strong financial results. We ended the quarter with NAV per share of $16.65, up $0.51 or 3.2% from the $16.14 we reported last quarter. Notably, our NAV now sits above what we reported in the Q4 of 2019, the final quarter before the onset of the global health crisis. We took aggressive action to manage our portfolio throughout the pandemic. We are very pleased to see our team's hard work reflected in our results. We again generated strong earnings this quarter with Net Investment Income of $0.39 per common share. We've declared a total dividend of $0.39, which represents a trailing 12-month dividend yield of 10.6% on our common stock and 9% on our Net Asset Value. In line with our dividend policy, investors can expect us to distribute substantially all of the excess income earned over our base $0.32 dividend. This quarter, we repurchased $6.8 million of our common stock, resulting in $0.02 of accretion to Net Asset Value. Recently, our Board of Directors reapproved our stock repurchase authorization for $150 million. At our stock's current valuation, we will continue to be purchasers of our common shares. I'll turn now to this quarter's investment activity in the portfolio. As you might imagine, given the continued strength in our markets, we posted another quarter of robust originations. We funded $270 million of new investments across an array of new and existing borrowers. Currently, the portfolio stands at just under $2 billion, and leverage remains in line with our target. As we look forward, our pipeline is healthy. We are confident in our ability to source attractive investments in this market. Credit fundamentals in the portfolio remain solid, and those investments most impacted by COVID continue to demonstrate cyclical recovery. Our internal risk ratings again improved as did the performance of our watchlist credits. We expect continued positive fundamental performance going forward and see opportunity in 2022 for improvements in our non-accrual investments. Finally, allow me to reflect back on the last few years at CGBD. When Taylor, Tom, and I took the helm in the Q2 of 2019, reestablishing strong investment performance was our top priority. On this front, I'm extremely pleased with the results our team has demonstrated. We've passed through a difficult cycle, and our NAV has grown across that period, while our earnings remain comfortably in excess of our base dividend. Our investment objective is the delivery of sustainable income. We have been consistently delivering against that goal. Going forward, we're fortunate to operate in attractive markets with both secular growth and strong relative investment value. The cycle is advancing, and there is ample competition. As you've heard and will continue to hear from us, our strategy to address this is to fully leverage our primary competitive advantage, the Carlyle platform. We focus our efforts on how best to use our platform to derive edge at each step of our investment process, from origination to credit to portfolio management. As we drive and deepen these initiatives, we're confident we can maintain a high degree of investment selectivity and regularly identify conviction investments, all while bringing a safe and defensive approach to portfolio construction. We will continue to focus on the long-term performance of the business with the goal of delivering attractive dividends and NAV stability to our shareholders. I'd like to hand the call now over to our Chief Investment Officer, Taylor Boswell. Good morning, everyone. It's nice to be with you again, and we're pleased to report another strong quarter of performance at CGBD. Today, we'll touch on macro and markets per usual, then I'd like to spend a few minutes on how we apply the benefits of Carlyle's platform to drive our investment success. Admittedly, it's a more complicated macro environment than the beginning of the year, when there were fewer observable risks to cyclical recovery. We saw the pace of global growth weaken in the Q3 due to the COVID-19 Delta variant and the persistence of global supply chain disruptions. The late 2020 and early 2021 boom in durable goods spending liquidated global manufacturing inventories, and restocking has proven difficult due to inadequate capacity and complex global production networks. With these conditions, elevated inflation has proven more persistent than previously anticipated. This has been further fueled in Q3 by sharp increases in global energy prices and elevated shipping costs. Meanwhile, employee shortages persist as the U.S. labor force participation rate remains approximately 2% below its pre-pandemic peak. In our portfolio, we're seeing certain instances of rising costs. However, generally, our borrowers are showing the ability to pass through cost increases, and as such, fundamental performance remains strong. This is consistent with the broader backdrop, where U.S. corporate earnings are expected to rise 30% from year-ago levels. On the new deal front, we continue to see robust activity across corporate transactional markets, and the Q3 was as busy as any in our history. Both the velocity and volume of this market are remarkable. Of course, velocity is a risk while volume is an opportunity. We're actively using the latter to mitigate the risk of the former by focusing our efforts on those deals where we have both high conviction and appropriate opportunity to conduct rigorous credit work. All in all, our market continues to offer attractive deployment opportunities for discerning investors. Last quarter, I discussed how we derive our investment advantage, even in competitive markets, which I'd summarize as follows. First, we have a leading position in true middle market first lien lending that forms the core of our portfolios. Second, we complement our core with risk factor diversifying specialty lending capabilities. Third, we utilize the Carlyle platform to create edge at all stages of our investment process. Today, I'll spend some time delving deeper into that third topic, which has been an enormous focus of ours over the last two years. In sourcing, our platform's large direct origination footprint and integrated approach materially increase deal volumes at the top of our funnel. Today, we source nearly a third of our deals from adjacent investment efforts within Carlyle's Global Credit Platform, who regularly see transactions more appropriate for our mandate than for their own. Over the last two years, as we've deployed and deepened our integrated approach, we have seen hit rates for new deals halve, meaning we are roughly twice as credit selective today as we once were. Top of the funnel breadth not only lets us get more selective at the bottom of our funnel, it also allows us to meaningfully reduce investment-specific risk. As an example, you'll see in the quarter we booked a new junior debt position in AP Plastics. Given the breadth of our origination footprint, we had this deal in-house over an extended period of time from four different highly engaged sponsors. This is a regular occurrence in our business, and it allows us to significantly enhance our diligence step compared to more narrow sourcing efforts. In diligence, our platform is an even more effective risk reducer. Being part of Carlyle allows us access to expertise across a wide variety of markets, sectors, and geographies, and we build our process to seek that edge in each transaction. For instance, in recent quarters, we've seen an uptick in sponsor interest in digital consultancy businesses as there are strong secular growth trends underlying the sector. We have a historically strong business services practice in Carlyle Credit, and seven digital consultancy deals have hit our direct lending desk in the last nine months alone. This is a great place to start, but our work doesn't stop there. When we access the Carlyle platform, we leverage the fact that our private equity teams are also focused on this space, and in fact, own an asset in the sector. We leverage the senior leaders of our IT organization who have deep, direct expertise contracting with these firms. We leverage our private equity portfolio companies to understand how they use and view these providers. This gives us both more and more direct expertise to inform our investment judgments as we seek to both minimize risk and capture opportunity. Finally, in workouts, we combine the deep and relevant experience of our private equity franchise with our platform's dedicated workouts team. We're not afraid to move aggressively to exit assets in which we have lost faith. We also have competitively advantaged workout capabilities, from staffing management teams and boards to designing and executing new corporate strategies. As such, we are equally unafraid to hold workout assets. In more instances than not, we find the cost of capital demanded by the market to exit assets undergoing transition is far too high, precisely because potential buyers don't have the same capabilities as we do. One should expect us to remain invested in these assets for longer periods of time so that we can leverage our capabilities to maximize outcomes. Indeed, you'll find that we've held our current non-accrual investments for an average of 10 quarters. As we look forward, with several years of hard work behind us, we believe these assets now generally stand on sound fundamental footing. Hopefully, this helps provide color on how we apply our platform to drive investment edge across our process. Over the last two years, we have been working hard to deepen these advantages, and we believe the results of those efforts are beginning to evidence themselves plainly in our investment performance. Our portfolio has passed through the severe shock of COVID and exited with higher NAV than we entered. We have consistently generated an attractive dividend. As we go forward, continued portfolio recovery offers an opportunity for both income and NAV improvement. Thanks as always for your time and support. Tom? Thank you, Taylor. Today, I'll begin with a review of our Q3 Earnings that'll provide further detail on our balance sheet positioning and conclude with a discussion of our portfolio. As Linda previewed, we had another impressive quarter on the earnings front. Total investment income for the Q3 was $44 million. That's up from $43 million in the prior quarter. The primary driver was an increase in core interest income on our investment book, partially offset by lower other income. While OID accretion from repayments experienced a moderate increase, while the income from the two JVs again remained stable versus prior quarter levels. Total expenses were up modestly at $22 million in the quarter. The result was Net Investment Income for the Q3 of $21 million or $0.39 per common share, exceeding both recent performance and the general guidance we've provided the last few quarters. On November 1st, our Board of Directors declared the dividends for the Q4 of 2021 at a total level of $0.39 per share. That comprises the 32-cent base dividend plus a $0.07 Supplemental, which is payable to shareholders of record as of the close of business on December 31st. Similar to prior quarters, as we look forward to the Q4 and into 2022, we remain very confident in our ability to comfortably deliver the $0.32 Base dividend, plus continue the sizable supplemental dividends. Moving on to the performance of our two JVs. Total dividend income was again $7.5 million, in line with the last two quarters. On a combined basis, our dividend yield from the JVs was about 11%. Going forward, we continue to expect stable dividend generation from the two JVs similar to this quarter's results. On the valuations, our total aggregate realized and unrealized net gain was $26 million for the quarter. The sixth consecutive quarter of positive performance following the drop in March 2020. As Linda noted, NAV is now back above December 2019 levels. Using the same buckets I've outlined in prior quarters, we again saw broad-based improvement across each category. First, the performing lower COVID-19-impacted names, plus our equity investments in the JVs increased in value about $14 million compared to June 30. The largest components were an $8 million increase in the value of our investment in MMCF 1, plus $5 million in gains from our equity co-investment book. Second, the assets that have been underperforming pre-pandemic, some which have COVID exposure, were up $5 million, marking the sixth consecutive quarter of stability or improvement. The final category is the moderate to heavier COVID-impacted names. We continue to see improvement in the underlying financial performance of these borrowers. Collectively, they experienced a net $7 million increase in value. Of note, our investment in First Watch Restaurants, which we marked up during the Q3, repaid in full during October. Next, we'll touch on our financing facilities and leverage. We continue to be very well positioned with the right side of our balance sheet. Statutory leverage was about 1.3 times, while net financial leverage was about 1.1. Both increased modestly quarter over quarter given the net positive deployment in the investment book. Yet we're still sitting close to the lower end of our target range of 1.0-1.4, giving us flexibility to invest judiciously in the current robust deal environment. Regarding the preferred equity issuance from May 2020, as I said in prior quarters, it continues to be a long-term investment by Carlyle and our BDC, so there currently is no intention to convert. I'll also note that it accounts for only about 2.5% of our capital structure and is accreted to earnings on an unconverted basis. I'll finish with a review of our portfolio and related activity. We continue to see overall stability and improvement in credit quality across the book. The total fair value of transactions risk rated three to five, indicating some level of downgrade since we made the investment, devalued again this quarter by $16 million in the aggregate. Total non-accruals were essentially flat at 3.5% based on fair value, and this was the fifth consecutive quarter with no new non-accruals. As Taylor detailed, I want to take a moment to reiterate our philosophy on workouts. We have a dedicated workout function and significant resources across Carlyle that we use to maximize recovery when credits turn south. We don't manage our non-accrual statistics. We manage our non-accrual assets for maximum value realization. These situations often require the right mix of turnaround experience, incremental capital, and patience, all which we possess. We've used that combination in the past to achieve successful recoveries, and we're following a similar playbook on our current non-accruals, Derm, Direct Travel, and SolAero. Based on our continued focus and investment over a number of years, all else equal, we see a path to both NII expansion and increased recovery above our 9/30 valuations. With that, back to Linda for some closing remarks. Thanks, Tom. Before I turn the call over to the operator, I'd like to reiterate that delivering a sustainable and attractive dividend to our shareholders alongside a stable or growing NAV remains our top priority. We are pleased that we've delivered on this and believe we are very well positioned to continue to do so. Thank you for joining us today, and we here at Carlyle wish you and your families a safe and wonderful start to the holiday season. I'd like to now hand the call over to the operator to take your questions. As a reminder, to ask a question, you will need to press star one on your telephone. To withdraw your question, press the pound key. Please stand by while we compile the Q&A roster. Our first question comes from the line of Ryan Lynch from KBW. Your line is now open. Hey, good morning. Thanks for taking my questions. The first one, you gave some commentary in your introduction regarding, you know, some supply chain shortages and inflation pressures as being, you know, a fairly moderate concern right now in the marketplace, which is understandable. Does that change the specific industries that you guys are focusing on today when you guys are looking to deploy new capital? Or does that just influence the way you guys are due diligence-ing specific companies, making sure that their supply chains are set up well or that they can pass on increasing costs, you know, to their end markets? Hey, Ryan, thanks for the question. It's Taylor. The answer is absolutely on the latter, maybe a little less so on the former. Meaning that it really causes us to focus a lot more on near-term's earnings trajectory and proving out, you know, the price pass-through mechanisms of the borrowers that we have. That of course is a really important part of any underwrite and always will be, and then seeing those demonstrated in the current period as costs rise to recapture those and profitability. I think that it really causes us to kind of double down in those places, you know, where you might see those things happening. Naturally, you know, in an environment like this, you're gonna skew a little less towards, you know, highly labor-intensive business models, highly energy-intensive business models where you're seeing the most pressure. You know, it certainly doesn't rule out those sectors if you have confidence in your ability to underwrite and understand that, you know, the pricing capture is happening on the other side of cost pickup. Okay. Understood there. You know, really over the last couple quarters, you guys have had very strong portfolio activity, both on the originations and on the repayment side. It sounds like your pipeline remains pretty strong. I just wanted to know if you could give any color on, you know, what you guys are expecting. Are you guys expecting these levels to remain similar in the Q4 that we've seen maybe in the Q3 or to a lesser extent, the Q2? Or has anything changed, you know, as far as market activity or your guys' process that would slow that down? You know, overall, I mean, we're continuing to see very robust levels of activity and, you know, I don't think there's anything that's gonna change that. There is a little bit of seasonality in our business, where people kind of try to wrap their transactions, you know, before the Christmas holiday season and then new processes will kind of launch in the new year. You know, that's very normal and typical. Overall, we don't see anything going on in markets or in our business specifically, that are gonna stand in the way right now of this very robust volume environment. Yeah, Ryan, it's Linda. You know, I just would maybe point you to what we look at as sort of a leading indicator in that regard. We see, you know, a lot of capital being raised on the private equity side from folks like Carlyle all the way down the spectrum to private equity firms that are more focused, you know, on the more traditional middle market direct lending space as well. That gives us some confidence that the trajectory of the volumes that we're seeing will have some legs to it. Just one more from me. You mentioned you being able to tap into other parts of the Carlyle platform, you know, both from underwriting due diligence, but also very importantly to widen the funnel and create better, you know, origination opportunities. I think you said maybe a third of your deal flow is now coming from, you know, adjacent strategies across the Carlyle platform. I know the overall credit business is growing at Carlyle, which is benefiting the BDC. I'm just wondering, have there also been investments made, and if you could speak to those made within the direct lending platform to kind of grow the capabilities and the investment professionals at that platform, in addition to just getting additional deal flow from growth and other strategies across the credit platform? Yeah, Ryan, it's been an enormous focus of ours over the course of really the last five years here at Carlyle, when our credit platform has been significantly investing in private credit markets. If you look across our business, the number of headcount here dedicated to illiquid markets generally has probably doubled over that period of time. Some of that growth falls directly into our narrowly defined direct lending business. Some of it falls into functional areas that, you know, support our business, whether it be our capital markets teams or our research teams or otherwise, and some of it falls in those adjacent businesses. You know, we really have meaningfully participated as a business in the growth of these industries and, you know, shifted our resourcing as a platform dedicated towards those, these private credit industries over the last five years. The short answer is yes, a lot. Yeah. Ryan, maybe just to give you know, an anecdote, this morning, I had You know, just a conversational meeting with some of the direct lending team, and there were about a dozen of us in the room. I've been at Carlyle 22 years. I don't think there's been anybody else in that room that's been at Carlyle even 22 months. Everybody had been hired in 2020 and 2021. You know, really a focus on just you know, growing our resources and growing them in the right way with people who you know, we think are gonna be additive, both from an origination perspective and a credit research perspective. Understood. That's a helpful anecdote. Those are all my questions, but I did wanna, before I hop off, say congratulations, you know, on reaching the milestone of growing, you know, your NAV above pre-COVID levels. That's a big accomplishment, you know, certainly for any lender, you know, in this environment. Good work on that, guys. Thanks for recognizing that, Ryan. We really appreciate it. Thank you. Our next question comes from the line of Finian O'Shea from Wells Fargo Securities. Your line is now open. Hi, everyone. Good afternoon. Just a question on leverage. Tom, as you pointed out, there's a range of 1-1.4, and you're on the lower end. Just any color or context on how willing you are or interested you are in taking advantage of that in today's market, given we're seeing, you know, a lot of competition, wage and energy inflation and so forth. Like, how should we think about this runway as a near-term or a longer-term opportunity? Hey, good morning, Fin. Appreciate the question. It's Tom. You know, you've seen the last number of quarters. We've been running in that right around 1.05, right between 1.0 and 1.1. You know, we're very comfortable at that range right now. Certainly to the extent we see attractive opportunities in the market, there's room to grow there. You know, our target right now for the time being is remaining right in that current sweet spot where we are now, which certainly gives us the flexibility to increase if desired based on the market opportunities. Got it. That's all for me. Thanks so much. Thank you. Our next question comes from the line of Melissa Wedel from JP Morgan. Your line is now open. Good morning, everyone. Thanks for taking my questions today. Wanted to touch quickly on the repurchase activity, which seems to have been pretty stable quarter- to- quarter, and it sounds like that certainly at current levels and at a discount to NAV, that's likely to continue in the near term. Curious about how you're thinking about share repurchases headed into 2022. Thank you. Hey, good morning. It's Tom. You know, certainly we look closely at the level of the discount, and that's why we've been active buyers over the last number of years, except during the that March 2020, July to 2020 timeframe based on the impact of the pandemic. We've been steady purchasers. We anticipate continuing to be steady purchasers. But depending on the discount to NAV, you know, you could see that those numbers rightfully, we think rightfully, have gone down in the last couple of quarters. We think, you know, based on if we continue to trade, you know, in the eighties where we are now, we'll continue with that at that steady pace to the extent that NAV, as we anticipate, that discount should decrease, we should get closer to trading at NAV. You know, you could see those levels of repurchases decline. Got it. I appreciate that. I did have one clarification. I think it was a follow-up on Ryan's question about repayment activity in 4Q. I might have missed it. Did you touch on sort of what if you expect repayments to continue into the end of the year similar to what we've seen in the Q3? Hey, it's Tom. We know what it is. While the new deal environment, for all the reasons Taylor noted, continues to be very robust, we've definitely seen a pickup in repayment activity based on just the really robust M&A environment. Gets to Fin's question about where we are with leverage. As we look at this quarter, as we sit here today, we're probably looking at, you know, very robust new deal volume probably being offset by repayments in the books. We're seeing, you know, I'd say in the aggregate, a steady in terms of overall net deployment for the quarter in terms of not looking at too much portfolio growth leverage remaining in the range where we've been. Got it. Thank you so much. Yeah. It's Taylor, Melissa. I mean, I think that you know, we're feeling very confident generally in our ability to originate assets. You know, frankly, we could take up the funded asset level, you know, I think very comfortably in this environment if we wanted to. The focus here, right, is sustainable income generation, and we feel like we're earning at a really nice level right around where we are with the business, and we'll kind of live in this range, as Tom mentioned, as opposed to needing or wanting to drive higher or lower for some other reason. Understood. Very helpful. Thank you. Thank you. Our next question comes from the line of Ka ili Wang from Citi. Your line is now open. Good morning. Thanks for taking my question. Wondering if you could talk about how interest rate sensitive you are, and do you have any thoughts about, you know, potential inflationary pressures and how it affects the portfolio that you have? Yeah, sure. Morning. It's Tom again. You know, when you look at our portfolio, most of our loans are floating rate and have LIBOR floors. Our debt on the other hand. We've got our fixed rate tranches of notes. Our notes, our other, our revolving credit is floating rate. So, you know, to the extent that, you know, LIBOR has been low when it comes to SOFR, you know, it's at 10 basis points, it's at a low level. To the extent that that level creeps up to the 1% floor level, you know, you'll see some deterioration in earnings if, as LIBOR gets closer to that 1% floor. When it goes above the 1%, that's when we start to get some of that back. That's where you see the interest rate sensitivity. We have tables in our 10-Q spelling out the various levels. In terms of, we certainly have the benefit of the floors right now. To the extent interest rates go up, our interest expense would increase. We'd have some pressure from that perspective. Thanks. That's it for me. Thank you. At this time, I'm showing no further questions. I would like to turn the call back over to Linda Pace for closing remarks. Well, thanks everyone for joining us today. Hope you have a great day, and we'll see you after Q4 earnings. Thank you. This concludes today's conference call. Thank you for participating. You may now disconnect.